Liesbeth Lemmens

1.2k total citations
21 papers, 895 citations indexed

About

Liesbeth Lemmens is a scholar working on Genetics, Oncology and Hepatology. According to data from OpenAlex, Liesbeth Lemmens has authored 21 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 6 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Liesbeth Lemmens's work include Inflammatory Bowel Disease (14 papers), Colorectal Cancer Treatments and Studies (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Liesbeth Lemmens is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Colorectal Cancer Treatments and Studies (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Liesbeth Lemmens collaborates with scholars based in Belgium, Hungary and United States. Liesbeth Lemmens's co-authors include Paul Rutgeerts, Maja Noman, Gert Van Assche, Karel Geboes, Jan Ceuppens, Peter Suenaert, Benny Geypens, Veerle Bulteel, Geert D’Haens and Karel Geboes and has published in prestigious journals such as Gastroenterology, Annals of Oncology and The American Journal of Gastroenterology.

In The Last Decade

Liesbeth Lemmens

21 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liesbeth Lemmens Belgium 11 550 420 219 160 155 21 895
Magali de Bruyn Belgium 13 479 0.9× 299 0.7× 211 1.0× 200 1.3× 228 1.5× 31 836
Filip J. Baert Belgium 12 461 0.8× 340 0.8× 184 0.8× 204 1.3× 83 0.5× 35 704
Maria Carme Masamunt Spain 16 756 1.4× 409 1.0× 341 1.6× 364 2.3× 327 2.1× 39 1.3k
Masamichi Satomi Japan 14 648 1.2× 456 1.1× 314 1.4× 329 2.1× 184 1.2× 31 1.1k
Wee Chian Lim Singapore 11 458 0.8× 348 0.8× 232 1.1× 94 0.6× 88 0.6× 29 825
J Bauditz Germany 16 276 0.5× 401 1.0× 292 1.3× 192 1.2× 160 1.0× 27 1.2k
Fabio Cataldi United States 15 632 1.1× 303 0.7× 260 1.2× 364 2.3× 111 0.7× 72 1.0k
H J Hodgson United Kingdom 19 519 0.9× 478 1.1× 370 1.7× 269 1.7× 104 0.7× 44 1.1k
Masahiro Takahara Japan 16 373 0.7× 345 0.8× 276 1.3× 109 0.7× 135 0.9× 71 827
Edyta Szymańska Poland 13 553 1.0× 363 0.9× 229 1.0× 134 0.8× 109 0.7× 56 819

Countries citing papers authored by Liesbeth Lemmens

Since Specialization
Citations

This map shows the geographic impact of Liesbeth Lemmens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Lemmens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Lemmens more than expected).

Fields of papers citing papers by Liesbeth Lemmens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liesbeth Lemmens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Lemmens. The network helps show where Liesbeth Lemmens may publish in the future.

Co-authorship network of co-authors of Liesbeth Lemmens

This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Lemmens. A scholar is included among the top collaborators of Liesbeth Lemmens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Lemmens. Liesbeth Lemmens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedict, Ágnes, Lucjan Wyrwicz, Anna Horváth, et al.. (2020). A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective. ESMO Open. 5(5). e000850–e000850. 4 indexed citations
2.
Lemmens, Liesbeth, et al.. (2019). Quality of life (QoL) in metastatic colorectal cancer (mCRC) in the real world: Final results of a European survey. Annals of Oncology. 30. v247–v248. 1 indexed citations
3.
Lemmens, Liesbeth. (2016). ecancermedicalscience. ecancermedicalscience. 5. 220–220. 1 indexed citations
4.
Lemmens, Liesbeth. (2015). Nintedanib in Advanced NSCLC: Management of Adverse Events. PubMed. 5(1). 29–41. 10 indexed citations
5.
Segaert, Siegfried, et al.. (2009). Skin toxicities of targeted therapies. European Journal of Cancer. 45. 295–308. 52 indexed citations
6.
Lemmens, Liesbeth, et al.. (2008). Managing patients with metastatic colorectal cancer on bevacizumab. British Journal of Nursing. 17(15). 944–949. 16 indexed citations
7.
Rutgeerts, P., et al.. (2003). Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open‐label, pilot study. Alimentary Pharmacology & Therapeutics. 17(2). 185–192. 72 indexed citations
8.
Suenaert, Peter, Veerle Bulteel, Liesbeth Lemmens, et al.. (2002). Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. The American Journal of Gastroenterology. 97(8). 2000–2004. 316 indexed citations
9.
D’Haens, G., et al.. (2001). Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial. The American Journal of Gastroenterology. 96(9). 2564–2568. 67 indexed citations
10.
D’Haens, Geert, Liesbeth Lemmens, Frederik Nevens, et al.. (2001). Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 120(6). 1323–1329. 285 indexed citations
11.
Suenaert, Peter, Liesbeth Lemmens, Maja Noman, et al.. (2001). Anti-TNF treatment restores the gut barrier in Crohn's disease. Gastroenterology. 120(5). A518–A518. 4 indexed citations
12.
13.
Rutgeerts, Paul, Gert Van Assche, Geert D’Haens, et al.. (2000). Endoscopic characteristics of the relapse of Crohn's disease after inflixlmab (RemicadeR) therapy. Gastroenterology. 118(4). A568–A568. 3 indexed citations
14.
15.
D’Haens, Geert, Stefan Bourgeois, Martin Hiele, et al.. (2000). Two and four mg/kg/day of intravenous cyclosporine are equally effective in severe attacks of ulcerative colitis. Gastroenterology. 118(4). A786–A786. 3 indexed citations
16.
D’Haens, Geert, K. Geboes, Maja Noman, Liesbeth Lemmens, & Paul Rutgeerts. (2000). Etanercept (TNF receptor fusion protein, enbrel®) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial. Digestive and Liver Disease. 32. A42–A42. 1 indexed citations
17.
Rutgeerts, Paul, Geert D’Haens, Martin Hiele, et al.. (1999). Nitroimidazol antibiotics are efficacious for prophylaxis of postoperative recurrence of Crohn's disease: a placebo controlled trial. Gastroenterology. 116(4). 11 indexed citations
18.
Lemmens, Liesbeth, et al.. (1999). Remission of severe ulcerative colitis with cyclosporine monotherapy is effectively maintained with further immunosuppression. Gastroenterology. 116(4). 722. 2 indexed citations
19.
Lemmens, Liesbeth, et al.. (1999). Cyclosporine therapy for ulcerative colitis does not cause permanent renal damage. Gastroenterology. 116(4). 1 indexed citations
20.
Lemmens, Liesbeth, et al.. (1986). Acute focal bacterial nephritis (acute lobar nephronia).. PubMed. 69(6). 431–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magali de Bruyn Breakdown of academic impact, for papers by Filip J. Baert Breakdown of academic impact, for papers by Maria Carme Masamunt Breakdown of academic impact, for papers by Masamichi Satomi Breakdown of academic impact, for papers by Wee Chian Lim Breakdown of academic impact, for papers by J Bauditz Breakdown of academic impact, for papers by Fabio Cataldi Breakdown of academic impact, for papers by H J Hodgson Breakdown of academic impact, for papers by Masahiro Takahara Breakdown of academic impact, for papers by Edyta Szymańska
Rankless by CCL
2026